PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer

NCT02055690 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped Safety

Conditions

Ovarian Neoplasms
Neoplasms, Ovarian
Ovarian Cancer

Interventions

DRUG: Pazopanib
DRUG: Fosbretabulin

Sponsor

The Christie NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]